Mortsel, Belgium

Sofie Notebaert


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Sofie Notebaert

Introduction

Sofie Notebaert is a notable inventor based in Mortsel, Belgium. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. Her work focuses on innovative solutions for treating serious health conditions, including cancer.

Latest Patents

Sofie Notebaert holds a patent for Anti-PDGF-C antibodies. This invention relates to antibodies that bind to the PDGF-C antigen, which are capable of inhibiting the binding of PDGF-C to the PDGFRα receptor. Additionally, these antibodies inhibit PDGFRα activation by PDGF-C. The applications of such antibodies are crucial, especially in the treatment of cancer.

Career Highlights

Sofie Notebaert is associated with Thrombogenics NV, a company dedicated to developing innovative treatments for various medical conditions. Her work at Thrombogenics has positioned her as a key player in the biotechnology sector, contributing to advancements in therapeutic solutions.

Collaborations

Sofie collaborates with talented individuals such as Claudia Fromond and Hoa Thu Ngo. These partnerships enhance her research and development efforts, fostering innovation in her field.

Conclusion

Sofie Notebaert's contributions to biotechnology, particularly through her patent for Anti-PDGF-C antibodies, highlight her role as an influential inventor. Her work continues to pave the way for advancements in cancer treatment and therapeutic development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…